Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-23-003303
Filing Date
2023-11-29
Accepted
2023-11-29 16:33:08
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS II LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 64710
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 6058
  Complete submission text file 0000929638-23-003303.txt   72320
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Subject) CIK: 0001811623 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93757 | Film No.: 231452828
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

EIN.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G